Regulations.gov document
Use of Standards in the Food and Drug Administration’s Regulatory Oversight of Next…
Notice · FDA-2016-D-1270 · posted Jul 8, 2016
Key facts
| Document ID | FDA-2016-D-1270-0001 |
|---|---|
| Title | Use of Standards in the Food and Drug Administration’s Regulatory Oversight of Next Generation Sequencing-Based In Vitro Diagnostics Used for Diagnosing Germline Diseases; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2016-D-1270 |
| Posted | Jul 8, 2016 |
| Federal Register citation | 81 FR 44614 |
| FR document number | 2016-16201 |
| Comment period opens | Jul 8, 2016 |
| Comments due | Oct 7, 2016 |
| Effective date | Jul 8, 2016 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: